Publications

5543 Results

ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).

Authors
S Gholami;S Colby;D Horowitz;K Guthrie;A El-Khoueiry;CD Blanke;PA Philip;L Kachnic;S Ahmad;F Rocha
Journal / Conference
Ann Surg Oncol Mar;30(3):1364-1365
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36542251
Study Number(s)
S0809

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,000 women from 86 randomised trials. Early Breast Cancer Trialists’ Collaborative Group [SWOG collaborators GT Budd, W Barlow, K Albain, J Gralow, D Hayes, R Jagsi]

Authors
EBCT Collaborators
Journal / Conference
Lancet Apr 15;401(10384):1277-1292
Year
2023
Research Committee(s)
Breast
PMID
PMID37061269

Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

Authors
N Dimou;A Kim;O Flanagan;N Murphy;V Diez-Obrero;A Shcherbina;E Aglago;E Bouras;P Campbell;G Casey;S Gallinger;S Gruber;M Jenkins;Y Lin;V Moreno;E Ruiz-Narvaez;M Stern;Y Tian;K Tsilidis;V Arndt;E Barry;J Baurley;S Berndt;S Bezieau;S Bien;T Bishop;H Brenner;A Budiarto;R Carreras-Torres;T Wawan Cenggoro;A Chan;J Chang-Claude;S Chanock;X Chen;D Conti;C Dampier;M Devall;D Drew;J Figueiredo;G Giles;A Gsur;T Harrison;A Hidaka;M Hoffmeister;J Huyghe;K Jordahl;E Kawaguchi;T Keku;S Larsson;L Le Marchand;J Lewinger;B Mahesworo;J Morrison;P Newcomb;C Newton;M Obon-Santacana;J Ose;R Pai;J Palmer;N Papadimitrou;B Pardamean;A Peoples;P Pharoah;E Platz;J Potter;G Rennert;P Scacheri;R Schoen;Y Su;C Tangen;S Thibodeau;D Thomas;C Ulrich;C Um;F van Duijnhoven;K Visvanathan;P Vodicka;L Vodickova;E White;A Wolk;M Woods;C Qu;A Kundaje;L Hsu;W Gauderman;M Gunter;U Peters
Journal / Conference
British Journal of Cancer Aug;129(3):511-520
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID37365285
PMC
PMC10403521
Study Number(s)
S0000

Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization

Authors
SD King;S Veligenti;M Brouwers;Z Ren;W Zheng;V Setiawan;L Wilkens;X Shu;A Arslan;L Beane Freeman;P Bracci;F Canzian;M Du;S Gallinger;G Giles;P Goodman;C Haiman;M Kogevinas;C Kooperberg;L Le Marchand;R Neale;K Visvanathan;E White;D Albanes;G Andreotti;A Babic;S Berndt;L Brais;P Brennan;J Buring;K Rabe;W Bamlet;S Chanock;C Fuchs;J Gaziano;E Giovannucci;T Hackert;M Hassan;V Katzke;R Kurtz;I Lee;N Malats;N Murphy;A Oberg;I Orlow;M Porta;F Real;N Rothman;H Sesso;D Silverman;IM Thompson;J Wactawski-Wende;X Wang;N Wentzensen;H Yu;A Zeleniuch-Jacquotte;K Yu;B Wolpin;E Duell;D Li;R Hung;S Perdomo;M McCullough;M Freedman;A Patel;U Peters;E Riboli;M Sund;A Tjonneland;J Zhong;S Van Den Eeden;P Kraft;H Risch;L Amundadottir;A Klein;R Stolzenberg-Solomon;S Antwi
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention Sep 1;32(9):1265-1269
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37351909
PMC
PMC10529823
Study Number(s)
S0000

The effect of old age treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG Oncology Group/Gynecologic Oncology Group study

Authors
T Sia;W Tew;C Purdy;D Chi;A Menzin;J Lovecchio;M Bookman;D Cohn;D Teoh;M Friedlander;D Bender;D Mutch;D Gershenson;K Tewari;R Wenham;A Hendrickson;R Lee;H Gray;A Alvarez Secord;L Van Le;S Lichtman
Journal / Conference
Gynecologic Oncology Jun;173:130-137
Year
2023
Research Committee(s)
Gynecologic
PMID
PMID37148580
PMC
PMC10414765
Study Number(s)
G0182

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

Authors
CW Ryan;C Tangen;E Heath;M Stein;M Meng;A Alva;S Pal;I Puzanov;J Clark;T Choueiri;N Agarwal;R Uzzo;N Haas;T Synold;M Plets;U Vaishampayan;B Shuch;IM Thompson;PN Lara
Journal / Conference
Lancet Sep 23;402(10407):1043-1051
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37524096
PMC
PMC10622111
Study Number(s)
S0931

Granulomatous and Sarcoid-like Immune Related Adverse Events Following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and A Literature Review

Authors
I Eljilany;A Noor;M Paravathaneni;I Yassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
Cancers (Basel) Apr 29;15(9):2561
Year
2023
Research Committee(s)
Melanoma
PMID
PMID37174027
PMC
PMC10177189
Study Number(s)
CTSU/E1609, S1404

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial

Authors
R Krouse;G Anderson;K Arnold;C Thomson;V Nfonsam;M Al-Kasspooles;J Walker;V Sun;A Alvarez Secord;E Han;A Leon-Takahashi;D Isla Ortiz;P Rodgers;S Hendren;M Sanchez Salcedo;J Laryea;W Graybill;D Flaherty;H Mogal;T Miner;J Pimiento;M Kitano;B Badgwell;G Whalen;J Lamont;O Guevara;M Senthil;S Dewdney;E Silberfein;J Wright;B Friday;B Fahy;S Anantha;M O'Rourke;M Bakitas;J Sloan;M Grant;G Deutsch;J Deneve
Journal / Conference
Lancet Gastroenterology and Hepatology Aug 1;S2468-1253(23)00191-7
Year
2023
Research Committee(s)
Palliative Care
PMID
PMID37541263
PMC
PMC10530384
Study Number(s)
S1316

Outcomes of Black (B) versus White (W) patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) with or without orteronel (Ort): Analysis of pt-level data from SWOG-1216 phase 3 trial

Authors
N Sayegh;U Swami;Y Jo;C Tangen;G Gebrael;B Haaland;S Gupta;M Plets;M Hussain;D Quinn;P Lara;IM Thompson;N Agarwal
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 6532); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1216

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by Total Mesorectal Excision (TME) for treatment of locally advanced rectal cancer (LARC)

Authors
D Schrag;S Quian;M Weiser;M Gollub;L Saltz;G Chang;R Auer;J Farma;T George;V Gordon;B Musher;J Goldberg;T Kolevska;A Dueck;E Basch;A Venook;K Goodman;E O'Reilly;J Meyerhardt;H Mamon
Journal / Conference
J Clin Oncol 41, 2023 (suppl 17; abstr LBA2); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), plenary session - oral
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N1048